Cellectar Biosciences, Inc. Retained Earnings
Cellectar Biosciences, Inc. (CLRB) had Retained Earnings of -$281.72 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$281.72M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$274.79M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$269.13M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$263.84M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$281.72M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$274.79M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$269.13M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$263.84M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$259.39M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$253.95M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$247.34M 10-K · filed 2026-03-04 | |
| 2024-09-30 | -$244.99M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | -$230.32M 10-Q · filed 2024-10-29 | |
| 2024-03-31 | -$229.40M 10-Q/A · filed 2024-10-29 | -$239.06M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$202.76M 10-K · filed 2025-03-13 | -$217.48M 10-K · filed 2024-03-27 |
| 2023-09-30 | -$194.88M 10-K/A · filed 2024-10-29 | -$210.03M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$177.36M 10-K/A · filed 2024-10-29 | -$196.30M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$167.18M 10-K/A · filed 2024-10-29 | |
| 2022-12-31 | -$159.99M 10-K/A · filed 2024-10-29 | -$179.50M 10-K · filed 2023-03-09 |
| 2022-09-30 | -$147.58M 10-K/A · filed 2024-10-29 | -$172.28M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$140.07M 10-K/A · filed 2024-10-29 | -$164.47M 10-Q · filed 2022-08-05 |
| 2022-03-31 | -$134.44M 10-K/A · filed 2024-10-29 | |
| 2021-12-31 | -$150.90M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$144.98M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | -$139.16M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$133.13M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | -$126.78M 10-K · filed 2022-03-21 | |
| 2020-09-30 | -$123.16M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$119.25M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$115.64M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$111.68M 10-K · filed 2021-03-02 | |
| 2019-09-30 | -$108.30M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$104.40M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | -$101.21M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | -$97.59M 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$93.76M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | -$90.75M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | -$87.83M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | -$84.35M 10-K · filed 2019-02-26 | |
| 2017-09-30 | -$80.27M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$76.80M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$73.68M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$70.79M 10-K · filed 2018-03-21 | |
| 2016-09-30 | -$68.20M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$65.92M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | -$63.78M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | -$64.61M 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$65.56M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$63.70M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$61.41M 10-Q · filed 2015-05-20 | |
| 2014-12-31 | -$59.11M 10-K/A · filed 2016-10-20 | -$59.17M 10-K · filed 2015-03-24 |
| 2014-09-30 | -$55.76M 10-Q · filed 2015-05-20 | -$56.59M 10-Q · filed 2014-11-12 |
| 2014-06-30 | -$56.09M 10-Q · filed 2014-08-04 | |
| 2013-12-31 | -$51.06M 10-Q · filed 2015-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |